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SUMMARY 
Vaccinology, as a great achievement of public health of the 20th century nowadays faces 
doubts, questions, and concerns that could be included in the term of vaccine hesitancy. The 
vaccinology in the 21st century is marked by the emerging anti-vaccine movements followed 
by a variety of attempts and approaches of professionals to resolve them. The globalization 
in health care on the one side and great technological achievements, on the other, create 
the possibilities where an enormous amount of data is publicly available. The professionals 
have based the benefits of vaccination on scientific data. Vaccine hesitancy and anti-vaccine 
movements declare that they have also based their policy on scientific data. On the first line 
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of facing parental vaccine hesitancy are primary care pediatricians. They can testify their own 
limiting abilities to do so, as well as the limiting abilities of other professionals involved in 
vaccinology. In the situation of an enormous amount of data, they could be drowned out 
and interpreted in various ways. It is clear that the old-fashioned “defense” of the great public 
achievement of the 20 century - vaccinology - is no longer appropriate. On the other hand, a 
search of the literature shows the entry of “Big Data” into medicine in general and the public 
health and vaccinology. This paper attempts to position the role of Big Data (its benefits, 
traps, and ethical implications) in vaccinology in the 21st century based on the literature 
research and our propositions.
Keywords: vaccinology, Big Data, ethics of Big Data, immunization practices.
1. Vaccinology
Vaccination is a “public health intervention aimed at preventing infection related to 
mortality, morbidity and disability”1. As Delany stressed2, the story of vaccinology 
started in 1721 with the introduction of variolation from Asia to Europe. The first 
vaccine against smallpox was introduced in 1796. By the end of the 20th century, 
vaccination became the procedure of the highest achievements of public medicine. 
This achievement helps “build a society free of vaccine-preventable diseases and 
save lives of millions of children across the globe”3. Regardless of the facts which 
support vaccination programs, we have suboptimal coverage rates, especially among 
the vulnerable population, such as preterm infants, newborn, oncology patients, 
pregnant women, patients with the immune-related disease, elderly people, etc4. 
The world entered the 21st century with the first therapeutic vaccine and reverse 
vaccinology in 2013. The development of vaccine shifts from reductionists towards 
the holistic approach or system biology5 trying to predict immunogenicity after the 
vaccination by the computational help. It is estimated that the vaccination program 
1  Bragazzi, N.L., Gianfredi, V., Villarini, M., Rosselli, R., Nasr, A., Hussein, A., Martini, M., Behzadifar, M. 
(2018), Vaccines Meet Big Data: State-of-the-Art and Future Prospects, From the Classical 3Is (“Isolate-Inactivate-
Inject”) Vaccinology 1.0 to Vaccinology 3.0, Vaccinomics, and Beyond: A Historical Overview. Front Public 
Health, 6, 62.
2  Delany, I., Rappuoli, R., De Gregorio, E. (2014), Vaccines for the 21st century, EMBO Mol Med, 6 (6), 
708–20. 
3  Delany, I., Rappuoli, R., De Gregorio, E. (2014), 708–20.
4  Cotugno, N., Ruggiero, A., Santilli, V., Manno, E.C., Rocca, S., Zicari, S., Amodio, D., Colucci, M., Rossi, 
P., Levy, O., Martinon-Torres, F., Pollard, A.J., Palma, P. (2019), OMIC Technologies and Vaccine Development: 
From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines, J Immunol Res, 
2019, 8732191.
5  Blohmke, C.J., O’Connor, D., Pollard, A.J. (2015), The use of systems biology and immunological big data to 
guide vaccine development, Genome Med, 7, 114.
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saves over 3 million lives of children per year6  as well as saves millions of dollars of 
the health care cost7 that could be used otherwise.
The new social moments in 21st-century life with globalization, economic growth, 
immigrations, and new infections have to lead to a new vaccination paradigm. 
Despite all the scientific data regarding the benefits of vaccination for our lives, 
vaccination medicine is one of the most questioned procedures in medicine in the 
last couple of decades. There are anti-vaccine movements across the globe, and the 
hesitancy of parents rises every day. The immunization has been accused as the 
cause of different types of adverse reactions: allergic reactions, cause of autoimmune 
diseases, autism, and much more8. Vaccinology crosses the path “from the lifesaving 
procedure” to the most questionable procedure in medicine in a very short period. The 
science is on one end, and the anti-vaccination movement’s unverified information 
is on the other end of the vaccinology story. There are many reasons for suboptimal 
vaccine coverage, but we can summarize them in two; most of the physicians have 
not had the chance to see or treat a child with a vaccine-preventable disease, such 
as diphtheria or poliomyelitis, and the second reason is that there is a suspicion 
regarding the efficacy and safety of the vaccine9. 
Lately, we have been witnessing that anti-vaccine-oriented visitors of symposia 
dedicated to vaccination turn the discussion towards the necessity of explaining 
fundamental medical knowledge. A similar thing occurs during the public 
presentation of immunization.  There is an impression that we have turned back 
to explaining the elementary level of knowledge regarding preventable childhood 
diseases and their impact on children’s lives and health. The globalization in health 
care on the one side and great technological achievements, on the other side, creates 
the possibilities where an enormous amount of data is publicly available.  The source 
of those data is the product of a large scientific work area from all fields of human 
knowledge. On the other hand, a significant amount of data came from activities 
of social infrastructure10. There is a question of how we can navigate through the 
enormous amount of data regarding the vaccination? To which data should we trust, 
to which we should not trust? Who posted those data on the Internet? Which review is 
representative, which is not? Bragazzi et al., in their paper, emphasize that information 
and communication technologies can positively influence parental vaccine-related 
6  André, F.E. (2003), Vaccinology: past achievements, present roadblocks and future promises, 21 (7-8), 593–5.
7  Brennan, B. (1998), Vaccines: the wave of the future, Perspect Health, 3 (2), 17–21.
8  André, F. E. (2003), 593–5.
9  Cotugno, N. Et al. (2019), 8732191.
10  Vayena, E., Blasimme, A. (2017), Biomedical Big Data: New Models of Control Over Access, Use and 
Governance, J Bioeth Inq, 14 (4), 501–513.
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knowledge, attitudes, beliefs, and vaccination willingness11. Sometimes the impression 
is that the negative connotation on vaccination (regardless of its relevance) reaches 
better the general audience better. To keep the welfare of vaccination on the life and 
health of children and population in general, to prevent returning to times when 
the preventable childhood disease has taken millions of children’s lives, the necessity 
of reachability, understanding, and organization of scientific information regarding 
the vaccination has been raised. For example, medical agencies (FDA - Food and 
Drug Administration, EMEA – European Medicine Agency, HALMED Croatian 
Agency for Drugs and Medical Products, etc.) collect the data regarding the adverse 
reactions to vaccination. In other words, we have respectable Big Data regarding 
the adverse reaction to vaccination. The professionals had to find a way to make Big 
Data available and easily accessible to the general population, pediatricians, or other 
interested parties. Google Trends can be used to monitor how often people search 
the Internet for information regarding the vaccination, or it can help us see if the 
search was spontaneous or induced by media, or give us information regarding the 
specificity of information that was searched 12. Based on this kind of information, a 
specialist can address the parents and the public with the specific information that 
they seek. 
The literature search shows the entry of “Big Data” in medicine in general and in 
public health and vaccinology. We searched mainly database PubMed for the search 
topics “Vaccination and Big Data”, “Immunization and Big Data”, and “Big Data”. 
A group of experts by consensus selected the papers we used in this work13. This 
paper is an attempt to position the role of Big Data (its benefits, traps, and ethical 
implications) in vaccinology in the 21st century based on exploring the literature and 
our propositions regarding the same. 
2. Big Data
We all witness a huge amount of data circulating each second. The data are created, 
gathered, and processed14. The appearance of Big Data is due to the digitalization in 
11  Bragazzi, N.L, Barberis, I., Rosselli, R., Gianfredi, V., Nucci, D., Moretti, M., Salvatori, T., Martucci, 
G., Martini, M. (2017) How often people google for vaccination: Qualitative and quantitative insights from a 
systematic search of the web-based activities using Google Trends, Hum Vaccin Immunother, 13 (2), 464–469. 
12  Ibid, 464–469. 
13  Ibid.
14  Vayena, E., Blasimme, A. (2017), 501–513.
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everyday life and health care settings, on the one hand. On the other hand, is the 
emergence of computational analytic techniques15.
The expression “Big Data” was introduced by Roger Margoles16 in order to explain 
the situation of overloading the web with a huge amount of data measured in 
exabytes 1018 and zettabytes 1021. There are many definitions of Big Data. One of 
the definitions states that they are “datasets whose size is beyond the ability of typical 
database software tools to capture, store, manage, and analyze”17. Costa defined Big 
Data as “a new generation of technologies and architectures, designed to extract 
value from large volumes of a wide variety of data by enabling high-velocity capture, 
discovery, and analysis”18. More recently, the HMA-EMA Joint Big Data Taskforce 
has defined Big Data as “extremely large datasets which may be complex, multi-
dimensional, unstructured and heterogeneous, which are accumulating rapidly and 
which may be analyzed computationally to reveal patterns, trends, and associations. 
In general, big data sets require advanced or specialized methods to provide an answer 
within reliable constraints”19.
 Big Data may be characterized by three V-s: Volume, Variety, and Velocity20. Volume 
- the great amount of information presents the challenge for creating a model for 
storing these data. The Variety of data emphasizes that data can be “structured”, “semi-
structured”, or “unstructured”. Velocity or data in motion refers to the speed with 
which data are generated. The Value of data is characteristic of Big Data technology 
structured to extract value from the enormous extent of different data. The last V 
stands for the Veracity of data characterized by Accuracy, Certainty, and Precision21.
Big Data interfere with various segments of our lives, such as business, science, 
government, national security, transports, health care22, social science, pleasure, etc. 
15  Ienca, M., Ferretti, A., Hurst, S., Puhan, M., Lovis, C., Vayena, E. (2018), Considerations for ethics review 
of big data health research: A scoping review, PLoS One, 13 (10), e0204937.
16  Emani, C.K., Cullot, N., Nicolle, C. (2015), Understandable Big Data: A survey, Computer Science Review, 
17, 70–81. Available at https://www.cs.helsinki.fi/u/jilu/paper/bigdatasurvey01.pdf  (Accessed: 8 October 2019)
17  Manyika, J.,  Chui, M., Brown, B.,  Bughin, J., Dobbs, R., Roxburgh, C., Hung Byers, A. (2011), Big 
data: The next frontier for innovation, competition, and productivity, McKinsey Global Institute, available at 
https://www.mckinsey.com/~/media/McKinsey/Business%20Functions/McKinsey%20Digital/Our%20
Insights/Big%20data%20The%20next%20frontier%20for%20innovation/MGI_big_data_exec_summary.
ashx, (Accessed: 6 October 2019). 
18  Costa, F. (2014), Big data in biomedicine, Drug Discov Today, 19 (4), 433–40.
19  European Medicine Agency. HMA-EMA Joint Big Data Taskforce. Summary Report EMA/105321/2019, 
2019.
20  Hitzler, P., Janowicz, K. (2013), Linked data, big data, and the 4th Paradigm, Semantic Web 0 (0), 1, Available 
at http://www.semantic-web-journal.net/system/files/swj488.pdf, / (Assessed: 8 October 2019); Manyika, J., 
Chui, M., Brown, B.,  Bughin, J., Dobbs, R., Roxburgh, C., Hung Byers, A. (2011).
21  Manyika, J. et al. (2011).
22  Ienca, M. et al. (2018), e0204937.
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DIKW hierarchy (Data, Information, Knowledge, and Wisdom)23 could be applied 
in the area of Big Data. 
Figure 1: The DIKW pyramid  
Source: Soloviev, K., (2016)24 
The knowledge hierarchies represent the process of transformation of a concept from 
a lower level to the concept or entity on a higher level25.  In the knowledge hierarchy26 
(Figure 1), the data are symbols that represent the properties of objects. The data are 
results of observation with no value by itself27. The data have various forms and 
various origins. To fulfill the mission, data have to be true. As Frické mentioned, 
data are created for a particular purpose limiting their usefulness in other situations. 
The next step in the pyramid is information. This is the step where data are processed 
and become information. In the process of processing data, some of the data are lost. 
The information can answer the questions about what, where, and when28. In the 
DIKW pyramid, the semantic information is essential for the “Weak knowledge” in 
this case. The next step has brought us to the level of knowledge, the level at which 
23  Frické, M. (2009), Knowledge pyramid, The DIKW hierarchy, J INF SCI, 35 (2), 131–142; Rowley, J. 
(2007), The wisdom hierarchy: representations of the DIKW hierarchy, J. Inf. Sci, 33 (2), 163–180.
24  Soloiev, K. (2016), 3 Steps to a Data-Driven Content Quality Approach. Exploring the role of Big Data 
in Official Statistics, Available at http://blog.contentquo.com/blog/3-steps-to-data-driven-quality-approach/, 
(Accessed: 3 November 2019).
25  Rowley, J. (2007), 163–180. 
26  Soloiev, K. (2016), 3 Steps to a Data-Driven Content Quality Approach. Exploring the role of Big Data 
in Official Statistics, Available at http://blog.contentquo.com/blog/3-steps-to-data-driven-quality-approach/, 
(Accessed: 3 November 2019).
27  Zhang, G.L., Sun, J., Chitkushev, L., Brusic, V. (2014), Big data analytics in immunology: a knowledge-based 
approach, Biomed Res Int,  2014, 437987.
28  Ibid.
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we know-how, which gives us the answer to how and why. At this point, information 
becomes instruction. The last level in the DIKW pyramid is wisdom, which includes 
mental component and could never be automatized and could never occur without a 
human. The wisdom is called wide knowledge, the point of knowledge for practical 
and ethical problem-solving. According to Ackoff29, wisdom includes values and 
judgment. Our schooling is not based on the development of judgment nor the 
generation of information. Humankind, unfortunately, learns to reach wisdom in 
a hard way. These were the words Ackoff said in 1999. The digitalization of human 
life twenty years later confirmed these words even more. The amount of each DIKV 
pyramid level in our lives decreased from the bottom of the pyramid to the top. We 
are surrounded by a huge amount of data that do not mean anything. 
3. Source of Big Data 
The origin of Big Data has an enormous, unprecedented width. It comes from 
heterogeneous sources30. A part of these data comes from the scientific area, a part 
of them comes from government activities, part of them comes from the non-
government sector, and a part of them comes from social activities, individual 
activities, interest groups, etc. The data can be available on the Internet, TV, or paper 
media. The author of data can be traced or known, or the author could not be 
traceable. Assuming we try to imagine possible ways of all the availability of our 
data (social, professional, financial, health, emotional, entertainment, sport), we can 
conclude that each of us can hardly have control over our data. 
Biomedical data are made up of phenotypic, genotypic, behavioral, and environmental 
data31.
The chart of Vayena, Dzenowagis, and Langefeld, named “Evolving health data 
ecosystem”, systematically presented the possible origin of  “biomedical big data” 32, 
such as health services, public health activities, biomedical research, data derived from 
exposure to environmental factors, data from lifestyle and socioeconomic conditions, 
data derived from behavioral and social habits. The authors list the stakeholders, 
such as individuals and groups, health services, academia and research, health care 
industry, data ITC industry, and government. 
29  Ackoff, R. (1999), From data to wisdom. Ackoff’s Best, New York, Joh Wiley§ Sons 170–172, http://faculty.
ung.edu/kmelton/Documents/DataWisdom.pdf (accessed: 5 November 2019). 
30  Ienca, M. et al. (2018), e0204937.
31  Vayena, E., Blasimme, A. (2017), 501–513.
32  Vayena, E., Dzenowagis Jand Langefeld, M. (2016), Evolving health data ecosystem, World Health 
Organization, https://www.who.int/ehealth/resources/ecosystem.pdf, (Accessed: 8 October 2019).
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This information can have an impact on an individual and population level. The 
impact can be positive, hopefully, useful for improving the health care of individuals 
and the population. However, on the other hand, it could have negative connotations, 
such as manipulation on an individual or population level.  
What is the situation regarding our health data? Where can personal health data be 
found?
What is with the “national” health data? 
Big Data can be used or tracked from social media platforms, such as Twitter for the 
prognosis of the disease, or Facebook for prevention of suicide, for checking seasonal 
pollen calendar, or for managing asthma33.
4. Ethics of Big Data
The data growth to the level of billion gigabytes irreversibly changes their morality, 
socio-economic status, and epistemic status34. Big Data technologies raise ethical 
concerns and questions. The ethical quality35 of Big Data is the amount of data, 
which is the largest in the history of humankind, and it comes to 2015-5-billion 
gigabytes every 10 seconds; the organic attribute of Big Data – while collecting every 
digital data better represents reality; the globality of Big Data enables global benefit; 
Big Data emphasizes the correlation of data over the cause of data. Data access, 
data privacy, and data validation in clinical trials are the biggest challenges that need 
ethical guidelines36.
Privacy, personal autonomy, and solidarity could be compromised in relation to Big 
Data nowadays37.
Privacy becomes hard to protect. It is almost impossible to achieve the anonymization 
of Big Data. The ethical question is raised regarding the ability to analyze Big Data 
towards planning the tendencies of some persons, such as the tendency to be a 
criminal before committing a crime. Big Data helps us in education and study on 
the one hand, but while using it to collect new knowledge and write a new paper, we 
cannot know how to protect our digital fingerprints. Last year, the EU’s High-Level 
33  Ienca, M. et al. (2018), e0204937.
34  Lipworth, W., Mason, P.H., Kerridge, I. (2017), Ethics and Epistemology of Big Data, J Bioeth Inq, 14 (4), 
485–488.
35  Zwitter, A. (2014), Big Data Ethics, Big Data§ Society, July-December, 1–6. https://journals.sagepub.com/
doi/pdf/10.1177/2053951714559253, (Assessed: 8 November 2019).
36  Ienca, M. et al. (2018), e0204937.
37  Vayena, E., Salathé, M., Madoff, L.C., Brownstein, J.S. (2015), Ethical challenges of big data in public health, 
PLoS Comput Biol, 11(2), e1003904.
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Expert Group on Artificial Intelligence published “Ethical Guidelines” with the most 
important “requirements which AI systems should meet”, including privacy and data 
governance38.
For generations, informed consent was a successful tool in protecting health care 
data accompanied by autonomy, privacy, and trust39. With the growth of the online 
world, the old famous informed consent started to lose control over human values 
of privacy and confidentiality. To protect these values, humankind needs a new 
approach. Vayena and Blasimme offer three approaches to those fundamental values: 
data portability rights, in terms of data access control, a new model of informed 
consent, in terms of data usage control, and participatory data management, in terms 
of data control by way of involvement in data governance. 
The protection of Big Data is questionable on the personal and institutional level. 
How can we protect our biomedical data? On the primary health care level, there 
are computational programs for the storage of health care data. The patient, himself/
herself, gives data to the physician. There are data regarding the diagnostic results, 
regarding the physicians’ clinical observation, there are also data that come from 
other medical professionals, such as conciliar exams, and community nurse. The 
patients should have access to these data, the primary care physician should also have 
access, and some other health care professionals should have access if the patient gives 
his/her permission. In addition to them, there are other employees in this office. 
There is informatics back up of the institution. There are controlling managers of 
the institution where the primary health care doctor works, unknown people who 
manage the whole software, and controllers of health care institutions. It is obvious 
that the individual patient cannot control their health care data. If we ask ourselves, 
for example, who is responsible for controlling, managing, or accessing these data, it 
is hard to find an exact answer. The situation is similar at the level of secondary and 
tertiary health care. Only in these situations it is more difficult to secure the control 
of Big Data in health care. 
How can Vayena et al.’s three models of data control, use, access, and governance be 
applied in the mentioned situation is hard to imagine. It requires specific computer 
abilities, knowledge, and legal framework for a start. 
If we speculate about adding some other data on the previously mentioned, the 
illusion of data control is bigger and more realistic, as Brandimarte et al. discussed in 
38  High-Level Expert Group on Artificial Intelligence (AI HLEG), https://ec.europa.eu/digital-single-market/
en/high-level-expert-group-artificial-intelligence.
39  Vayena, E., Blasimme, A. (2017), 501–513.
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their article40. A similar situation occurs regarding the ownership of biomedical Big 
Data. The control of Big Data and the secondary use of data are ethical challenges 
nowadays41. 
The position of Ethics committees in the contents of Big Data should be revaluated. 
The guidelines regarding the approval of research, which needs access to millions 
of personal data, should be created. Lence et al., in their review, show that only 
13% of evaluated papers provided a specific normative recommendation for 
ethic committees42. There are real possibilities of de-identification of previously 
anonymized data. The anonymized data in the era of Big Data (digitalized data) and 
computational possibilities of analyzing those data become a utopia. 
The computational and methodological abilities of members of ethics committees 
are questioned because, without them, the members of ethics committees will not be 
able to resolve the ethical challenges of Big Data in health care settings43.
The big ethical question is the knowledge of particular physicians and particular 
patients regarding the world of Big Data. In the term of the world, we allude on 
the comprehensive amount of the Big Data available to help patients. A part of IT 
knowledge and possibilities scare us more. The physicians are not educated regarding 
the computational possibilities; they are not educated regarding the statistical 
possibilities. The methodology for exploring the possibilities of Big Data is unknown 
to us. Physicians are not computational people, they are not statistical people, but 
they are responsible for respecting ethics and law to protect patients’ health care 
data.  For example, in the Health Care Centre of Primorsko Goranska County, in 
which the first author of this article works as a pediatrician, as in other health care 
institutions throughout the world, the medical professionals had to sign the paper 
regarding the privacy of patient health care information. In the previous paragraph, 
we mentioned the known, and we imagine the unknown individuals who have access 
to health care information. It seems that average physicians today should be educated 
in computational and methodological fields to be able to use the benefits of Big Data 
in the treatment of their patients. Due to the gathered information, the question is 
whether the medical study’s computational professional would be a better solution 
for the patients in the area of healthcare-oriented Big Data.
40  Brandimarte, L., Acquisti, A., Loewenstein, G., Babcock, L. (2009), Privacy Concerns and Information 
Disclosure: An Illusion of Control Hypothesis, IDEALS, https://www.ideals.illinois.edu/bitstream/
handle/2142/15344/Privacy_concerns_and_information_disclosure.pdf?sequence=2&isAllowed=y, (Accessed: 23 
October 2019).
41  Ienca, M. et al. (2018), e0204937.
42  Ibid.
43  Ibid.
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5. Big Data in health care 
Emerging of Big Data in health care settings can result in preventive, diagnostic, and 
therapeutic benefits44 from medical blogs and health records.
The health care data can be derived from Electronic Health Records, mobile health 
applications and web-networks, health care robotics, medical internet, direct-to-
consumer genetics, and screening tests45. The source can also be a nonmedical data 
source, such as personal dietary programs, fitness club membership, etc. 
The potential positive impact of Big Data on clinical settings is enormous, such as 
the creation of epidemiological models, continuous monitoring of patient’s health, 
and the benefit in public and individual health. Ienca et al. reviewed the literature 
from 2012-2017 regarding the article on health related to Big Data. Their results 
show that the number of such articles is 131 times higher than in the period 2001-
200546. The authors show potential benefits in the research, preventive medicine in 
individual cases and at the public level, in clinical medicine, such as personalized 
medicine, diagnostics, clinical decision-making, health monitoring, and improving 
patient safety and therapy. 
In this study, seven challenges arise regarding the Big Data in health care settings:
a. Technical challenges in the sense of data security, data quality, data storage, data 
linkage, and data reuse. 
b. The methodological challenge in the sense of methods used in the study, 
standardizing the data and metadata, collecting and processing the data, 
monitoring the usage of data.
c. The regulatory challenge in the sense of directive regarding the ownership of data, 
detecting the potential risk with using and managing the data.
d. The social challenge in the sense of relevance for human society and the members 
of human society.
e. Infrastructural challenges in the sense of possibilities of existing infrastructures.
f. The financial challenge in the sense of financial possibilities of data storage sites.
g. Ethical challenges in the sense of moral principles. The privacy and confidentiality 
issue, informed consent, fairness and justice, trust and data ownership were most 
examined.
44  Ienca, M. et al. (2018), e0204937.
45  Ibid.
46  Ibid.
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Table 1: The terms and the definition of the terms used in paper 
Term  Definition 
Big Data47
“Large sets of data” with different level of structuration, 
emanating from different sources, “produced with 








“Quantitative measurements on a global scale and provide 
the ability to interrogate more than just the genome or 
transcriptome. The ability to comprehensively probe the 
proteome, metabolome, interactome, fluxome, lipidome, 
imflammasome”.
Vaccinomics50  “The application of immunogenetics and immunogenomics to the study of vaccine-induced immune response”. 
Adversomics51
“The application of immunogenomics and systems biology 
approaches to understand the genetic and non-genetic drivers 
of vaccine adverse reactions at the molecular level.”
Reverse vaccinology52 “The use of genomic data and in silico analyses to rapidly identify antigens for vaccine use”.
Systems vaccinology53
“The application of systems biology methods to 




“Optimal personalized vaccine approach, consisting of an 
optimal vaccine formulation, route of administration, adjuvant, 
dose, and dosing schedule (for vaccines that require multiple 
doses) for an individual or group of individuals”.
Genomics55 Systemic, genome-wide investigation of genes 
47  Ienca, M. et al. (2018), e0204937.
48  Vayena, E., Blasimme, A. (2017), 501–513.
49  Kennedy, R.B., Poland, G.A. (2011), The top five “game changers” in vaccinology: toward rational and 
directed vaccine development, OMICS 15 (9), 533–7.
50  Ibid.
51  Whitaker, J.A., Ovsyannikova, I.G., Poland, G.A. (2015), Adversomics: a new paradigm for vaccine safety and 
design, Expert Rev Vaccines, 14 (7), 935–47.
52  Poland, G.A., Kennedy, R.B., McKinney, B.A., Ovsyannikova, I.G., Lambert, N.D., Jacobson, R.M., Oberg, 
A.L. (2013), Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in 
the 21st century, Semin Immunol, 25 (2), 89–103.
53  Maure, C.G., Dodoo, A.N., Bonhoeffer, J., Zuber, P.L. (2014), The Global Vaccine Safety Initiative: enhancing 
vaccine pharmacovigilance capacity at country level, Bull World Health Organ, 92 (9), 695–6.
54  Whitaker, J.A., Ovsyannikova, I.G., Poland, G.A. (2015), 935–47.
55  Bragazzi, N.L. et al. (2018), 62.
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6. The place of Big Data in Vaccinology
As we mentioned earlier, vaccination saves millions of lives worldwide. Despite this, 
there are still unrealized protections from various infections, such as pandemic of 
HIV, TB56 on the one hand. On the other hand, vaccine hesitancy and anti-vaccine 
movements question the great success of vaccinology in the past. 
The 21st century faces a new approach in the research and development of a vaccine. 
The outdated approach “Isolates, Inactivates and Injects” and “one fits for all” is 
excepted to be replaced with “person to person” and “Population to population” 
specificity in vaccinology57. Kennedy and Poland introduce five components of 
vaccinomics, a new term for creating a safe and effective vaccine. One of them 
is Bioinformatics and Data Analysis. The research and omics in vaccinology 
development are accompanied by a variety of huge amounts of data. It is necessary to 
have informatics and statistic logistics to organize and analyze such data in order to 
be useful and beneficial in the production of the vaccine. Nakaya et al. emphasize the 
collaboration of immunologists and computational scientists to generate data-driven 
hypotheses to clarify the mechanisms of protective immunity58. 
Bragazzi et al. give us the list of potential benefits of Big Data in vaccinology59. 
a.  The role of Big Data in vaccine discovery and design. As an example, they cite Bexero, 
the commercial name for a vaccine against Neisseria meningitides. The Bexero is an 
example of a web-based vaccine that was designed with the help of computational 
tools and algorithms, such as SORT, PSI_BLAST, and FindPatterns60.
b.  The place of Big Data in vaccine production and delivery. The pharmaceutical 
companies and computational companies together try to identify possible negative 
interference in the cold chain of vaccine transportation.
c.  The Vaccine campaigns could help Big Data with the prediction of epidemiological 
figures or monitoring the success of vaccine campaigns. The use of novel data 
streams today seems to belong more to the anti-vaccine movements than to the 
scientists who promote vaccination programs. It appears that scientists are closed 
into a narrow circle of people.
56  Nakaya, H.I., Pulendran, B. (2015), Vaccinology in the era of high-throughput biology, Philos Trans R Soc 
Lond B Biol Sci, 19, 370(1671). 
57  Bragazzi, N.L. et al. (2018), 62; Kennedy, R.B., Poland, G.A. (2011), 533–7; Poland, G.A., Ovsyannikova, 
I.G., Kennedy, R.B. (2018), Personalized vaccinology: A review, Vaccine, 36 (36), 5350–5357.
58  Kennedy, R.B., Poland, G.A. (2011), 533–7.
59  Bragazzi, N.L. et al. (2018), 62.
60  Ibid, 62.
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d.  Big Data can be used in the monitoring of vaccine efficacy. There are different 
possibilities in doing so. One possibility is to collect data regarding the outbreaks 
of preventable diseases.
e.  The Benefit of Big Data in Vaccinology can be demonstrated in the collection of 
side effects of vaccination.  Serious immunological reactions are very rare61. In 
March 2012, the World Health Organization (WHO) initiated the Global Vaccine 
Safety Initiative with the aim of creating a global support structure for vaccine 
safety62 by creating a network of countries across the globe to detect and analyze 
adverse reactions. This initiative could help monitor public concern regarding the 
vaccination with the aim to predict and plan the potential intervention. 
However, their effect on public perception regarding the vaccination has multiple 
negative connotations. Every physician has a duty to report a side effect of a 
medicine. The same is with the vaccine. The patients also have the opportunity 
to report side effects. If we imagine the amount of data on the vaccine’s side 
effects reported to FDA, EMA or in Croatia to HALMED and to other medical 
agencies, we have an enormous amount of data, which represent worldwide data 
particular product’s side effects. The amount is in a million data information on, 
for example, MoPaRu side effects. The circle would be closed if each physician 
and patient could have such information on a regular basis. There are such data 
available, but we are often not aware of them, and we do not use them to confirm 
the information that is of unknown origin or origin that is not based on scientific 
ground. 
At this point, we would like to refer to the DIKW pyramid in the condense of 
anti-vaccine movements last decades. From basic science through clinical research, 
which ended with a particular vaccine in a pediatric office, scientists used huge 
amounts of data trying to build a particular vaccine against the causative agent of a 
specific disease. In this process, they use achievements achieved in the past, as well 
as setbacks experienced in the past, today’s achievements and experiences, novel 
possibilities, the help of medicine, the help of computing professionals to create a 
vaccine beyond one fit for more.
f.  The place of Big Data in vaccine hesitancy. Big Data can help scientists in tracking 
the elements that push parents to vaccine hesitancy. By exploring those elements, 
the professionals can give correct answers to patients’ questioning and fear. 
61  Stone, C.A. Jr, Rukasin, C.R.F., Beachkofsky, T.M., Phillips, E.J., (2019), Immune-mediated adverse reactions 
to vaccines, Br J Clin Pharmacol . doi: 10.1111/bcp.14112. [Epub ahead of print]
62  Maure, C.G., Dodoo, A.N., Bonhoeffer, J., Zuber, P.L. (2014), 695–6.
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We witness today that there are patients who do not have an adequate immune 
response to vaccination. We are not able to predict who will have serious adverse 
reactions to vaccination. The history of vaccine development is empirical. The 
paradigm one fits for all is based on ignorance of the complexity of the human 
immune system and host genome63. This situation helps in spreading anti-vaccine 
movements globally. The emphasis of the anti-vaccine movement is placed on serious 
adverse reactions, on the one hand, and vaccine ineffectiveness, on the other, pushing 
aside the facts of a million lives saved among the pediatric population since the 
beginning of the vaccinology era. 
The values of analysis of Big Data or high-dimensional data in vaccinomics are 
elaborated by Oberg et al.64. The generation, analysis, and modeling Big Data can be 
useful in the prediction of vaccine responses. Personalized vaccinology is directed to 
the right vaccine for the right patient in an appropriate time to prevent the disease 
while staying free of the vaccine sides effect. This scenario would be ideal for patients 
and for physicians at the same time. To achieve this goal, it is very important to make 
an appropriate study design, chose the exact antibody level, predict the occurrence 
of the immune response, etc. The important component in vaccinomics is adequate 
statistical modeling, which can detect possible associations between phenotype 
properties and explanatory variables. 
Poland et al.65, in the review, elucidate the meaning of personalized vaccinology. 
Current knowledge in vaccinomics and adversomnics helps to understand and 
provide answers on how to identify a patient with a higher risk of infection, or who 
has a higher risk for inadequate immunogenicity or serious adverse reactions, or how 
to determine the optimal vaccine dose for an optimal immunological response. The 
resulting solution leads us to personalized vaccinology in the future. To predict the 
personalized vaccine, it is necessary to assess genetic background, sex, and some other 
factors, such as age, weight, race, or medical condition. Cotugno et al. emphasize 
the necessity of personalizing vaccination in a vulnerable population66 because of 
their weaker vaccine-specific immunity response, such as antibody production in 
transplanted patients.
Poland et al.67 have offered the first mathematical model and predictive 
equitation for predetermined immune response:
63  Poland, G.A. et al. (2013), 89–103.
64  Oberg, A.L., McKinney, B.A., Schaid, D.J., Pankratz, V.S., Kennedy, R.B., Poland, G.A. (2015), Lessons 
learned in the analysis of high-dimensional data in vaccinomics, Vaccine, 33 (40), 262–70.
65  Poland, G.A., Ovsyannikova, I.G., Kennedy, R.B. (2018), 5350–5357.
66  Cotugno, N. et al. (2019), 8732191.
67  Poland, G.A. et al. (2013), 89–103.
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 y = β 0 +∑ p i =1 β i x i +ε 
y   measure of a person’s immune response
β0 is the intercept
βi  is the coefficient or slope for the ith variable 
xi  and indicates the amount of change in y for a 1unit change in xi
ε   random deviations from this model
By creating the “right” equation, scientists could be more rapid, direct, and rational 
in the development of a new vaccine that would be effective, safe, and without side 
effects. 
To recognize genetic variants that can influence adaptive vaccine induced immune 
response. The polymorphism of HLA, KIR, MICA, and BTN genes have an influence 
on the immune response to immunization against several diseases (influenza, 
smallpox, and hepatitis B)68. It is known that there are sex differences in the humoral 
and cellular immune response to the vaccine and indicate that adverse reactions 
are higher in the female. The mechanism that causes sex differences in the immune 
response is not well known69. Obesity is one factor that is connected with impaired 
immunogenicity. 
The adversomics with the goal of identification, characterization, and prediction of 
adverse reaction could be one of the answers to anti-vaccine movement. If we could 
predict maladaptive immune response that could cause the damage in the host, we 
would avoid such a vaccine70. Berkovic et al.71 give an example of sodium channel 
gene SCN1A mutation in possible vaccine encephalopathy. They studied 14 patients 
with alleged vaccine encephalopathy that occurred after the first of three dosed 
of diphtheria- pertussis – tetanus and diphtheria -pertussis- tetanus –inactivated 
polio – Haemophilus influenzae type b vaccine in infancy. In the 9 of 11 cases, the 
investigator found de novo mutation. The epidemiological studies did not correlate 
encephalopathies and vaccine, while the individual cases indicated so. 
Adjuvants in vaccine production have been placed in a vaccine hesitancy 
environment as a negative component. In contrast, Cotugno et al. gave examples 
where the development of adjuvants can enhance immune response72. Adjuvant 
68  Cotugno, N. et al. (2019), 8732191.
69  Poland, G.A., Ovsyannikova, I.G., Kennedy, R.B. (2018), 5350–5357.
70  Ibid.
71  Berkovic, S.F., Harkin, L., McMahon, J.M., Pelekanos, J.T., Zuberi, S.M., Wirrell, E.C., Gill, D.S., Iona, 
X., Mulley, J.C., Scheffer, I.E. (2006), De-novo mutations of the sodium channel gene SCN1A in alleged vaccine 
encephalopathy: a retrospective study. Lancet Neurology, 5 (6), 488–92.
72  Cotugno, N. et al. (2019), 8732191.
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development and OMICS technologies can increase the knowledge regarding the 
vaccine hyporesponsiveness. 
On the way to personalized vaccinology, the scientists have to overcome the following 
challenges73: larger genotype: phenotype datasets, integration of Big Data, consider 
in addition to the humoral immune, the cellular immune response; upgrade of 
biostatistical and bioinformatics approach; overcome financial difficulties in low and 
middle-income countries.  
If we analyze the anti-vaccine movement arguments, we face a level of data or 
information. It is hard to achieve a level of wisdom in explaining why not use a 
vaccine. The whole anti-vaccine movement is often shrouded in conspiracy theories, 
in which case the reason to argue on the level of knowledge and wisdom stops because 
of the conspiracy. The shocking information regarding the side effects of vaccines, the 
shocking web pages with a picture of a skull and a syringe, which represent vaccines, 
are data for which we are not sure whether they are true or not. Furthermore, we are 
unable to track the origin of such data. They are often not processed into information 
or knowledge or wisdom. However, they shockingly fulfill their purpose.
As the process of debating the vaccine issue goes on, both sides arguing without 
wisdom jeopardize the historical achievements of vaccinology in our lives. Hinman 
and Orenstein propose new action and new strategies to achieve the Global Vaccine 
Action Plan (GVAP)74. The new GVAP is necessary to respond to the global burden 
of vaccines today. 
Vaccinology is not a dogma; we should be able to discuss different issues on the topic, 
trying not to argue on the level of data.
The language of Big Data 
The use of language is related to the communication between the patient and the 
physician. In this communication, the physician is in a superior position due to the 
knowledge of both the topic and the terminology. On the other hand, the patient is 
always in a subordinate and inferior position, as his/her knowledge of the topic and 
the topic related terminology is limited75. It often leads to a misunderstanding, which 
is the result of the unequal language competence of interlocutors. With the entry of 
Big Data in medicine in general, we should switch our minds and abilities towards 
73  Poland, G.A., Ovsyannikova, I.G., Kennedy, R.B. (2018), 5350–5357.
74  Hinman, A.R., Orenstein, W.A. (2017), Collaborating to achieve Global Vaccine Action Plan goals, Lancet, 
390 (10093), 451–452.
75  Nikolić-Hoyt, A. (2003), Semantička adaptacija engleskih posuđenica u hrvatskom jeziku, Filologija, 41, 
169–184.
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the new communications. We have new parties in the communication process, the 
computational scientists with their own language and their way of communication. 
In order to transfer data and knowledge from the world of computational science to 
the world of medicine, both doctors and patients could be in a subordinate position. 
The availability of Big Data in vaccinology could be jeopardized because of a lack of 
abilities to understand the language of computational science. 
7. Conclusion 
The essence of the term Big Data can hardly be imagined in our everyday lives. 
Without computational knowledge, the amount of data available on a particular 
issue, such as in this paper on vaccinology, is hard to comprehend. Big Data in 
health care settings and vaccinology provide us with a great opportunity to improve 
vaccination effectiveness and reduce the vaccine’s side effects. As we stressed in the 
paper, the adversomics is one of the “branches” of Big Data that is very important 
today. The worldwide population is uncertain regarding the possible side effects of 
the vaccine. The use of Big Data in the analysis of the possible side effects and later 
in the production of vaccines, which can avoid the appearance of these side effects, 
would be a great achievement of Big Data in vaccinology. Another important issue of 
Big Data in vaccinology is personalized vaccinology that avoids the old paradigm one 
fits all. Big Data could help us develop technologies to produce vaccines considering 
sex, weight, gene, phenotypes, etc. 
There are many other possibilities that vaccinology can gain from Big Data, for 
example, through epidemiological studies, to create a campaign for successful 
vaccination. Anti-vaccination movements are powerful today76. Vaccine hesitancy 
was listed among the ten most significant threats to global health by the World 
Health Organization in 201977.
The size of Big Data extends the size of data that used to be available in the previous 
studies. Without computational science, Big Data regarding vaccinology would stay 
on the bottom level of knowledge information, on the level of data. We need the 
computational knowledge to collect data, analyze and create, and conclude or correlate 
among those data. The involvement of different experts in areas once dedicated only 
to medical professionals could present an ethical dilemma in the future.
76  Tucak, I. (2017), Obvezno cijepljenje djece: za i protiv, in: Rešetar, Branka et al. eds., Suvremeno obiteljsko 
pravo i postupak, Obiteljskopravna biblioteka, Pravni fakultet Osijek, 137–165. 
77  World Health Organization. Ten threats to global health in 2019. https://www.who.int/news-room/feature-
stories/ten-threats-to-global-health-in-2019, (Accessed: 23 October 2019).
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In this paper, we have also stressed some ethical implications regarding Big Data, 
such as privacy and confidentiality, that demand a new approach in protecting the 
privacy and informed consent of the individual. Vaccinology and Big Data raise 
the question of which countries of individuals will have the opportunity to benefit 
from new omics technologies. We can conclude that Big Data in vaccinology bring 
us more benefits. We have to take advantage of Big Data in vaccinology with the 
incorporation of ethical standards by guaranteeing the global use of beneficial fruits 
of Big Data in vaccinology and protecting the old foundations of ethics, such as 
privacy, confidentiality, and informed consent. 
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Mjesto golemih podataka (Big Data) 
u rješavanju sve većih problema 
vakcinologije u 21. stoljeću  
SAŽETAK
Cijepljenje se danas, kao veliko dostignuće javnog zdravstva dvadesetog stoljeća, suočava s 
dvojbama, pitanjima i sumnjama koje se mogu povezati s pojmom neodlučnosti odnosno 
nesigurnosti. Vakcinologiju 21. stoljeća obilježava porast protuvakcinalnih pokreta koji 
su popraćeni odgovorima stručnjaka s različitih aspekata u cilju rješenja i odgovora. 
Globalizacija u zdravstvu s jedne strane, kao i velika tehnološka postignuća s druge strane, 
stvaraju okolnosti u kojima je enormna količina podataka javno dostupna. Stručnjaci temelje 
dobrobit cijepljenja na znanstvenim podatcima. Isto se tako i roditelji, koji su neodlučni po 
pitanju cijepljenja, kao i protivnici cijepljenja, također pozivaju na činjenicu da svoje stavove 
temelje na znanstvenim činjenicama. Pedijatri u primarnoj praksi prvi su koji se susreću s 
roditeljima koji su neodlični po pitanju cijepljenja, a sve više svjedoče nemogućnostima da 
im se suprotstave, kao i nemogućnostima drugih stručnjaka koji su uključeni u cijepljenje. 
U okolnostima u kojima postoji enormna količina podataka lako je izvući jedan određeni i 
interpretirati ga na različite načine. Jasno je kako stari način „obrane“ položaja cjepiva kao 
jednog od velikih postignuća 20. stoljeća nije više primjeren. S druge strane, istraživanje 
literature ukazuje da pojam golemi podatci (Big Data) naveliko ulazi u medicinu općenito kao 
i u područje javnog zdravstva i cijepljenja. Ovaj rad ima za cilj, temeljem istraživanja literature 
i stavova autora, pozicionirati ulogu golemih podataka, Big Data, (dobrobiti, zamke, etičke 
implikacije) u cijepljenju 21. stoljeća.
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